As the landscape of clinical research evolves, the importance of inclusivity and diversity in clinical trials has never been more paramount. Join us to gain comprehensive insights and implications for diversity action plans in clinical trials.
Navigating the Maze of Diversity in Clinical Trials: Understanding and Implementing FDA Guidances
As the landscape of clinical research evolves, the importance of inclusivity and diversity in clinical trials has never been more paramount. Citeline, along with very special guests, aim to provide comprehensive insights and implications for diversity action plans in clinical trials. This informative webinar delves into the complexities and nuances of the latest FDA guidances on collecting race and ethnicity data in clinical trials.
Key points covered during this webinar include:
Strategies for Protocol Planning: Learn how to integrate diversity considerations into clinical trial designs from the ground up. We will discuss methods for creating protocols that are inclusive and representative of diverse populations.
Patient Engagement and Recruitment: Tackling the challenges of engaging and recruiting a diverse participant pool. The session will provide practical tactics for overcoming barriers to participation and ensuring that trials are accessible to underrepresented groups.
Data-Driven Approaches and Real-World Data (RWD): Discover how to leverage data analytics and real-world data to inform diversity strategies in clinical trials.
Implications of the FDA Webinar: Understanding its objectives and requirements for diversity action plans in clinical trials. We will explore how this act aligns with broader equity and inclusion goals in clinical trials and cover diversity components of the FDORA 2022 Act.
FDA Guidance on Race and Ethnicity Data Collection: An in-depth analysis of the FDA's guidelines for collecting and reporting race and ethnicity data. We'll discuss best practices for ensuring compliance and the significance of this data in enhancing trial outcomes.
Interactive Q&A Session: The webinar will conclude with an interactive session, allowing attendees to pose questions and discuss challenges they face in implementing these guidelines and practices.
Speakers
Natalie Monegro
Director, Clinical Trial Diversity & Inclusion
Abbvie
Leo Russo, PhD
Vice President and Head of Global Medical Epidemiology
Pfizer
Lorena Kuri
Head of Diversity Strategy
Bristol Myers Squibb
Clare Gibson
Associate Director, Global Demographics & Diversity Analytics
GSK
Claire Riches
Vice President, Clinical Solutions
Citeline
Fenwick Eckhardt
Senior Manager, New Product Development Strategy
Citeline
Lakan Thomas
Senior Clinical Solution Consultant
Citeline
Natalie Monegro
Director, Clinical Trial Diversity & Inclusion
Abbvie
Leo Russo, PhD
Vice President and Head of Global Medical Epidemiology
Pfizer
Lorena Kuri
Head of Diversity Strategy
Bristol Myers Squibb
Clare Gibson
Associate Director, Global Demographics & Diversity Analytics
GSK
Claire Riches
Vice President, Clinical Solutions
Citeline
Claire Riches is VP, Clinical Solutions at Citeline. Her role is to ensure Citeline’s data, new products, and services are meeting the needs and solving the challenges of the clinical industry. With over 25 years’ experience in the pharma industry within both clinical research and commercial strategy, Claire’s broad career encompasses multiple clinical fields, project management to client engagement, business unit head to therapeutic area lead in large pharma and CROs. She is passionate about the use of data and AI to support clinical decision making and increase probability of success, particularly in the areas of patient recruitment and increasing diversity.
claire.riches@citeline.com
Fenwick Eckhardt
Senior Manager, New Product Development Strategy
Citeline
Fenwick.Eckhardt@citeline.com
Lakan Thomas
Senior Clinical Solution Consultant
Citeline
View our Presentations
APR 23, 2024
11am
EST
Navigating the Maze of Diversity in Clinical Trials
As the landscape of clinical research evolves, the importance of inclusivity and diversity in clinical trials has never been more paramount. Join us to gain comprehensive insights and implications for diversity action plans in clinical trials.